Kupando has dosed the first patient in a Phase 1 [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]

Evogene has reported positive Phase 1 data for microbiome-based therapy [...]

Scancell Holdings has announced that the U.S. Food and Drug [...]

Scancell has reported updated results from its Phase 2 SCOPE [...]